Planning how to test the FearLess program with brain tumor patients and caregivers
Official title: FearLess in NeuroOncology
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This study is working out the best way to test a program called FearLess with people who have brain tumors and the people who care for them.
Read our full plain-language summary
What the trial team says
The overarching goal of this project is to assess the feasibility, acceptability, and appropriateness of recruitment methods, target population, and a waitlist design to finalize the protocol of FearLess in primary malignant brain tumor patients and caregivers
Key facts
- Registry number
- NCT06989086
- Stage of testing
- Not applicable
- Conditions studied
- Primary Malignant Brain Tumor, Glioblastoma (GBM), Astrocytoma, Oligodendroglioma, Caregiver
Where it is running
This trial lists 1 site.
-
Virginia
- Virginia Commonwealth University (Richmond)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.